Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

A Recent $314 Million Capital Raise Will Spike SOL-USD Higher

By Mark R. Hake, CFA

Solana Labs’ recent $314 million capital raise will push Solana crypto higher. Solana crypto is set to move higher as Solana Labs puts its recent capital raise to work promoting the crypto.

IBM Is Now Gushing Free Cash Flow, Making the Stock Worth Much More

By Mark R. Hake, CFA

IBM is now gushing free cash flow, making IBM stock worth much more. IBM stock is worth between at least 25% more at $183 and as much as 53% more based on its surging FCF.

The Dogecoin Recovery Could Take Longer Than You Think

By Mark R. Hake, CFA

Dogecoin is having a rough time since its Coinbase launch. It is down over 55% since its peak and may take a good while to recover.

Wish Stock Is Cheap, But It’s Not a Bargain

By Mark R. Hake, CFA

WISH stock is cheap because it is still not profitable with no free cash flow. It's worth 16% more at $12.86 but not further lacking FCF.

A Popularity Boost Means Stellar Lumens Could Rebound This Year

By Mark R. Hake, CFA

Stellar Lumens is gaining new accounts on its platform. With steady growth and a controlled token supply, XLM can easily rebound.

Vaxart Is Still Not Worth Anywhere Near Its Present Price

By Mark R. Hake, CFA

Vaxart is still not worth today's price. VXRT stock is worth no more than $6, especially if it's going to need another capital raise.

Cardano Will Double With Smart Contract Launch and Address Count

By Mark R. Hake, CFA

Cardano crypto is a good value here given its growth and smart contract launch. It will double as its address/value ratio matches Ethereum.

Litecoin Looks Set to Rebound Quite Significantly

By Mark R. Hake, CFA

Litecoin looks like it should rebound quite significantly. Given its high performance and historical correlation with Bitcoin, this cryptocurrency should recover soon.

Solana Crypto Looks Like Good Value with Its Super-Fast Standout Features

By Mark R. Hake, CFA

Solana crypto looks like good value here. Although well off its peak, Solana could rebound given its standout features for Dapps.

Overvalued Fisker Stock Is Headed To $7 Due To Capital Need

By Mark R. Hake, CFA

Fisker could need another capital raise so watch out. FSR stock could drop below $7 if spending continues at current rates.

Load More